未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Benefits of CMAB007 in Chinese Patients Having Inadequately Controlled Moderate/Severe Asthma With Increased Total IgE: A Randomized Phase 3 Trial具有增加总IgE水平的、中国中重度未控制哮喘患者中使用CMAB007的益处:一项随机III期试验
Lai, Kefang; Yan, Zhijun; Qian, Donghua; Zhang, Xiaoju; Bian, Tao; Dai, Xiaotian; Li, Huiping; Lin, Lin; Wang, Jin; Wang, Linwei; Yang, Jingping; Hu, Yaomin; Li, Hui; Nie, Xiuhong; Jin, Faguang; Li, Guoxiang; Sun, Shenghua; Xu, Feng; Zhao, Hui; Chen, Yusheng; Liu, Chuntao; Zhu, Huili; Li, Jing; Guo, Yajun; Zhong, Nanshan
分享
收藏
分享
收藏
分享
收藏Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer曲妥珠单抗Deruxtecan在早期乳腺癌残留HER2-Positive中的应用
Loibl, Sibylle; Park, Yeon Hee; Shao, Zhiming; Huang, Chiun-Sheng; Barrios, Carlos; Abraham, Jame; Prat, Aleix; Niikura, Naoki; Im, Seock-Ah; Li, Wei; Li, Huiping; Wang, Yongsheng; Yao, Herui; Kim, Sung-Bae; Geng, Cui-zhi; Rodriguez Pantigoso, Wuilbert; Ramirez Godinez, Francisco Javier; Song, Chuangui; Ching Chang, Yuan; Antoniazzi, Augusto; Chen, Shin-Cheh; Li, Zhigao; Nowecki, Zbigniew; Lim, Joline; Mathias, Elton; Sato, Yuta; Lu, Wenjing; Abdel-Monem, Hanan; Untch, Michael; Geyer, Charles E.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Real-world outcomes of first-line treatment with HLX02 versus reference trastuzumab plus pertuzumab in HER2-positive metastatic breast cancerHLX02与对照曲妥珠单抗联合帕妥珠单抗作为一线治疗在HER2阳性转移性乳腺癌中的真实世界疗效
Yan, Ying; Zhang, Ruyan; Li, Yanling; Di, Lijun; Gui, Xinyu; Jiang, Hanfang; Liang, Xu; Shao, Bin; Song, Guohong; Li, Huiping
分享
收藏Phase I trial of SPH4336, a novel cyclin-dependent kinase 4/6 inhibitor, in patients with advanced solid tumorsI期临床试验:SPH4336(一种新型细胞周期蛋白依赖性激酶4/6抑制剂)在晚期实体瘤患者中的应用
Jiang, Yu; Liang, Xu; Sun, Mei-Li; Gao, Ge; Gong, Yi; Li, Hui-Ping; Liu, Jie; Wang, Yong-Sheng
分享
收藏Bireociclib plus fulvestrant for HR+/HER2-advanced female breast cancer progressed on or after endocrine therapy: phase 3 BRIGHT-2 study interim analysisBirtociclib 联合 fulvestrant 治疗 HR+/HER2- 经内分泌治疗后进展的晚期女性乳腺癌:BRIGHT-2 研究 III 期中期分析
Wang, Jiayu; Zhang, Qingyuan; Li, Huiping; Tong, Zhongsheng; Ouyang, Quchang; Li, Huihui; Teng, Yuee; Wang, Biyun; Sun, Tao; Wang, Jingfen; Li, Wei; Niu, Zhaofeng; Li, Hongsheng; Gong, Chang; Wang, Shu; Wang, Xinshuai; Wu, Xinhong; Liu, Ning; Yu, Guohua; Liu, Fei; Duan, Xianghui; Wang, Shuya; Meng, Yaping; Wang, Li
分享
收藏
分享
收藏Anlotinib in combination with metronomic chemotherapy in HER2-negative metastatic breast cancer: an observational and retrospective study
Liu, Jiaxuan; Zhang, Jiayang; Li, Huiping; Song, Guohong; Di, Lijun; Jiang, Hanfang; Yan, Ying; Wang, Huan; Wang, Jing; Liu, Xiaoran; Shao, Bin; Li, Qiao
分享
收藏Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer基于Inavolisib的PIK3CA-Mutated晚期乳腺癌治疗
Turner, N. C.; Im, S-A; Saura, C.; Juric, D.; Loibl, S.; Kalinsky, K.; Schmid, P.; Loi, S.; Sunpaweravong, P.; Musolino, A.; Li, H.; Zhang, Q.; Nowecki, Z.; Leung, R.; Thanopoulou, E.; Shankar, N.; Lei, G.; Stout, T. J.; Hutchinson, K. E.; Schutzman, J. L.; Song, C.; Jhaveri, K. L.
分享
收藏
分享
收藏